Targeted therapy for oesophageal cancer: an overview
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10555-008-9117-z.pdf
Reference144 articles.
1. Ajani, J. A., van Cutsem, E., Moiseyenko, V., Tjulandin, S., Fodor, M., Majlis, A., et al. (2003). Docetaxel, cisplatin, 5-fluorouracil compare to cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastic carcinoma: Interim results of a randomized phase III trial (V325). Proceedings of the American Society of Clinical Oncology, 22, 229–237.
2. Blot, W. J., & McLaughlin, J. K. (1999). The changing epidemiology of oesophageal cancer. Seminars in Oncology, 26, 2–8.
3. Enzinger, P. C., & Mayer, R. J. (2003). Esophageal cancer. New England Journal of Medicine, 349, 2241–2252.
4. Mendelsohn, J., & Baselga, J. (2000). The EGF receptor family as targets for cancer therapy. Oncogene, 19, 6550–6565.
5. Lemmon, M. A., & Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends in Biochemical Sciences, 19, 459–463.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer;Anticancer Research;2022-07
2. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic;Seminars in Cancer Biology;2020-11
3. Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma;OncoTargets and Therapy;2016-06
4. The Molecular Biology of Thoracic Malignancies;Sabiston and Spencer Surgery of the Chest;2016
5. Cetuximab plus pemetrexed as second-line therapy for fluorouracil-based pre-treated metastatic esophageal squamous cell carcinoma;Cancer Chemotherapy and Pharmacology;2015-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3